U.S. markets open in 3 hours 38 minutes
  • S&P Futures

    4,258.50
    -28.00 (-0.65%)
     
  • Dow Futures

    33,819.00
    -162.00 (-0.48%)
     
  • Nasdaq Futures

    13,417.00
    -106.25 (-0.79%)
     
  • Russell 2000 Futures

    1,985.50
    -16.20 (-0.81%)
     
  • Crude Oil

    89.35
    -1.15 (-1.27%)
     
  • Gold

    1,767.20
    -4.00 (-0.23%)
     
  • Silver

    19.15
    -0.31 (-1.61%)
     
  • EUR/USD

    1.0077
    -0.0015 (-0.15%)
     
  • 10-Yr Bond

    2.8800
    0.0000 (0.00%)
     
  • Vix

    20.42
    +0.52 (+2.61%)
     
  • GBP/USD

    1.1873
    -0.0060 (-0.50%)
     
  • USD/JPY

    136.5860
    +0.7240 (+0.53%)
     
  • BTC-USD

    21,731.18
    -1,763.10 (-7.50%)
     
  • CMC Crypto 200

    516.60
    -41.13 (-7.37%)
     
  • FTSE 100

    7,554.48
    +12.63 (+0.17%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing

·2 min read
Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

"As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.